Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the pembrolizumab study, including its eligibility criteria, treatment arms, outcomes, locations, and record history.
    Difference
    57%
    Check dated 2026-11-08T14:40:16.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error rather than the clinical trial record.
    Difference
    0.2%
    Check dated 2026-11-01T15:41:50.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH notice says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T16:19:51.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T20:49:57.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T20:41:47.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record, replacing the detailed trial information with a standard error screen and eliminating access to the study's data on that page. This prevents viewing the trial details and related sections on the page.
    Difference
    20%
    Check dated 2026-09-20T20:01:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.